| 000 | 00951 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517054813.0 | ||
| 264 | 0 | _c20160804 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1399-3046 | ||
| 024 | 7 |
_a10.1111/petr.12605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTönshoff, Burkhard | |
| 245 | 0 | 0 |
_aShould we monitor mycophenolic acid plasma levels in pediatric renal transplantation? _h[electronic resource] |
| 260 |
_bPediatric transplantation _cNov 2015 |
||
| 300 |
_a665-6 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 773 | 0 |
_tPediatric transplantation _gvol. 19 _gno. 7 _gp. 665-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/petr.12605 _zAvailable from publisher's website |
| 999 |
_c25323292 _d25323292 |
||